Daphne S. Bakker

1.4k total citations
33 papers, 721 citations indexed

About

Daphne S. Bakker is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Daphne S. Bakker has authored 33 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Dermatology, 24 papers in Immunology and Allergy and 16 papers in Physiology. Recurrent topics in Daphne S. Bakker's work include Dermatology and Skin Diseases (33 papers), Allergic Rhinitis and Sensitization (23 papers) and Asthma and respiratory diseases (16 papers). Daphne S. Bakker is often cited by papers focused on Dermatology and Skin Diseases (33 papers), Allergic Rhinitis and Sensitization (23 papers) and Asthma and respiratory diseases (16 papers). Daphne S. Bakker collaborates with scholars based in Netherlands, Germany and United States. Daphne S. Bakker's co-authors include Marjolein de Bruin‐Weller, Judith L. Thijs, Femke van Wijk, Julia Drylewicz, Jorien van der Schaft, Lieneke F.M. Ariëns, Stefan Nierkens, Marlies de Graaf, Edward F. Knol and Barbara Giovannone and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Daphne S. Bakker

30 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daphne S. Bakker Netherlands	16	644	472	252	145	117	33	721
Usman Chaudhry United States	5	429 0.7×	307 0.7×	200 0.8×	90 0.6×	118 1.0×	7	504
Judith L. Thijs Netherlands	16	854 1.3×	667 1.4×	379 1.5×	155 1.1×	159 1.4×	31	991
Jesper Grønlund Holm Denmark	14	424 0.7×	261 0.6×	137 0.5×	139 1.0×	77 0.7×	26	553
Paola Facheris Italy	14	367 0.6×	190 0.4×	89 0.4×	79 0.5×	151 1.3×	36	489
Wojciech Francuzik Germany	14	178 0.3×	234 0.5×	79 0.3×	88 0.6×	47 0.4×	36	475
Shelbi Jim On United States	4	223 0.3×	147 0.3×	89 0.4×	61 0.4×	80 0.7×	4	274
Ryoji Tanei Japan	12	321 0.5×	239 0.5×	100 0.4×	51 0.4×	50 0.4×	23	467
Evangeline Pierce United States	12	374 0.6×	258 0.5×	96 0.4×	83 0.6×	48 0.4×	69	447
William Romero United States	9	321 0.5×	201 0.4×	94 0.4×	79 0.5×	62 0.5×	24	378
Pedro Mendes‐Bastos Portugal	10	314 0.5×	158 0.3×	57 0.2×	107 0.7×	98 0.8×	40	441

Countries citing papers authored by Daphne S. Bakker

Since Specialization

Citations

This map shows the geographic impact of Daphne S. Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphne S. Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphne S. Bakker more than expected).

Fields of papers citing papers by Daphne S. Bakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphne S. Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphne S. Bakker. The network helps show where Daphne S. Bakker may publish in the future.

Co-authorship network of co-authors of Daphne S. Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of Daphne S. Bakker. A scholar is included among the top collaborators of Daphne S. Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphne S. Bakker. Daphne S. Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruin‐Weller, Marjolein de, Celeste M. Boesjes, Lisa A. Beck, et al.. (2025). Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions. Allergy. 81(2). 326–344. 1 indexed citations

Boesjes, Celeste M., Daphne S. Bakker, Constance F. den Hartog Jager, et al.. (2025). Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment. Clinical & Experimental Allergy. 55(3). 260–263. 1 indexed citations

Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2024). Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy. Clinical & Experimental Allergy. 54(4). 241–252. 8 indexed citations

Stölzl, Dora, Lotte S. Spekhorst, Edward F. Knol, et al.. (2024). Type 2 Immune‐Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients. Clinical & Experimental Allergy. 55(1). 97–99.

Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease. Clinical and Translational Allergy. 13(1). e12221–e12221. 8 indexed citations

Boesjes, Celeste M., Nicolaas P. A. Zuithoff, Daphne S. Bakker, et al.. (2023). Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry. Acta Dermato Venereologica. 103. adv00872–adv00872. 16 indexed citations

Spekhorst, Lotte S., Celeste M. Boesjes, Laura Loman, et al.. (2023). Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry. British Journal of Dermatology. 189(3). 327–335. 20 indexed citations

Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis. Allergy. 78(8). 2266–2276. 15 indexed citations

Spekhorst, Lotte S., Daphne S. Bakker, Julia Drylewicz, et al.. (2022). Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Allergy. 77(11). 3398–3407. 31 indexed citations

10.

Boesjes, Celeste M., Nicolaas P. A. Zuithoff, Daphne S. Bakker, et al.. (2022). Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry. Acta Dermato Venereologica. 102. adv00820–adv00820. 12 indexed citations

11.

Spekhorst, Lotte S., Marlies de Graaf, Floris C. Loeff, et al.. (2022). Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis. JAMA Dermatology. 158(12). 1409–1409. 10 indexed citations

12.

Luijk, Chantal van, Daphne S. Bakker, Lotte S. Spekhorst, et al.. (2022). Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.. PubMed. 102. adv00666–adv00666. 7 indexed citations

13.

Luijk, Chantal van, Daphne S. Bakker, Lotte S. Spekhorst, et al.. (2022). Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis. Acta Dermato Venereologica. 102. adv00666–adv00666. 13 indexed citations

14.

Bakker, Daphne S., Marlot van der Wal, Barbara Giovannone, et al.. (2021). Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis. Journal of Investigative Dermatology. 141(8). 1943–1953.e13. 53 indexed citations

15.

Bakker, Daphne S., Marlies de Graaf, Stefan Nierkens, et al.. (2021). Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. Journal of Allergy and Clinical Immunology. 149(1). 125–134. 27 indexed citations

16.

Bakker, Daphne S., Lieneke F.M. Ariëns, Amanda Lans, et al.. (2020). Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis. The Journal of Allergy and Clinical Immunology In Practice. 9(3). 1389–1392.e2. 31 indexed citations

17.

Ariëns, Lieneke F.M., Jorien van der Schaft, Lotte S. Spekhorst, et al.. (2020). Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry. Journal of the American Academy of Dermatology. 84(4). 1000–1009. 63 indexed citations

18.

Bakker, Daphne S., Inge Haeck, Lieneke F.M. Ariëns, et al.. (2019). Dupilumab facial redness: Positive effect of itraconazole. JAAD Case Reports. 5(10). 888–891. 41 indexed citations

19.

Bakker, Daphne S., Julia Drylewicz, Stefan Nierkens, et al.. (2019). 418 Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment. Journal of Investigative Dermatology. 139(9). S286–S286. 1 indexed citations

20.

Bakker, Daphne S., F.M. Garritsen, Helen L. Leavis, et al.. (2018). Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs. Journal of Dermatological Treatment. 29(7). 682–687. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact